We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
-6.95%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$504M
AUM Growth
-$54.2M
Cap. Flow
-$8.09M
Cap. Flow %
-1.6%
Top 10 Hldgs %
26.94%
Holding
259
New
25
Increased
68
Reduced
75
Closed
24

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$9.31M
2
MLM icon
Martin Marietta Materials
MLM
+$5.87M
3
SNA icon
Snap-on
SNA
+$3.34M
4
IDXX icon
Idexx Laboratories
IDXX
+$3.22M
5
KHC icon
Kraft Heinz
KHC
+$2.74M

Top Sells

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$9.65M
2
MDT icon
Medtronic
MDT
+$8.91M
3
RL icon
Ralph Lauren
RL
+$7.08M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.39M
5
MMM icon
3M
MMM
+$3.83M

Sector Composition

Rank Sector Weight
1 Healthcare 23.07%
2 Technology 16.89%
3 Financials 14.17%
4 Consumer Discretionary 11.95%
5 Industrials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
101
AT&T
T
$161B
$1.27M 0.25%
51,710
+10,328
+25% +$263K
DVY icon
102
iShares Select Dividend ETF
DVY
$23.5B
$1.27M 0.25%
17,400
NSC icon
103
Norfolk Southern
NSC
$75.4B
$1.26M 0.25%
16,499
NKTR icon
104
Nektar Therapeutics
NKTR
$2.36B
$1.25M 0.25%
7,620
PCP
105
DELISTED
PRECISION CASTPARTS CORP
PCP
$1.21M 0.24%
5,260
INSM icon
106
Insmed
INSM
$21.4B
$1.2M 0.24%
64,729
SHPG
107
DELISTED
Shire pic
SHPG
$1.13M 0.22%
5,500
BDSI
108
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.11M 0.22%
199,375
+37,800
+23% +$279K
RARE icon
109
Ultragenyx Pharmaceutical
RARE
$2.46B
$1.1M 0.22%
11,455
-510
-4% -$58.4K
PBYI icon
110
Puma Biotechnology
PBYI
$386M
$1.08M 0.22%
14,395
+1,845
+15% +$174K
ABCO
111
DELISTED
Advisory Board Co
ABCO
$1.07M 0.21%
+23,475
New +$1.22M
QLTI
112
DELISTED
QLT Inc
QLTI
$1.06M 0.21%
398,700
+25,200
+7% +$92.5K
PFE icon
113
Pfizer
PFE
$143B
$1.04M 0.21%
34,881
-74
-0.2% -$2.37K
INTC icon
114
Intel
INTC
$458B
$1.01M 0.2%
33,481
-350
-1% -$10.1K
JAZZ icon
115
Jazz Pharmaceuticals
JAZZ
$15.8B
$950K 0.19%
7,150
BAC icon
116
Bank of America
BAC
$438B
$929K 0.18%
59,614
KYTH
117
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$924K 0.18%
12,325
VCRA
118
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$852K 0.17%
74,650
-4,200
-5% -$49.2K
GD icon
119
General Dynamics
GD
$104B
$820K 0.16%
5,940
BABA icon
120
Alibaba
BABA
$306B
$790K 0.16%
13,405
-7,160
-35% -$521K
BCRX icon
121
BioCryst Pharmaceuticals
BCRX
$2.25B
$787K 0.16%
69,000
LOW icon
122
Lowe's Companies
LOW
$119B
$777K 0.15%
11,275
JPM icon
123
JPMorgan Chase
JPM
$935B
$758K 0.15%
12,423
-484
-4% -$31.7K
IONS icon
124
Ionis Pharmaceuticals
IONS
$9.02B
$753K 0.15%
18,612
PFPT
125
DELISTED
Proofpoint, Inc.
PFPT
$745K 0.15%
12,350
-2,800
-18% -$174K

Similar funds

Franklin Street Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Franklin Street Advisors held 259 positions worth $504M, down 9.7% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Franklin Street Advisors's Q3 2015 filing shows 25 new, 68 increased, 75 reduced and 24 closed positions. Its largest new stake was PayPal: 259,960 shares worth $8.07M. The largest sale was eBay, an estimated $9.65M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Franklin Street Advisors's largest Q3 2015 buy was PayPal: 259,960 shares worth $8.07M.
  • Franklin Street Advisors added most to VF Corp in Q3 2015, an estimated $2.47M increase.
  • Franklin Street Advisors's biggest Q3 2015 reduction was eBay, cutting an estimated $9.65M.
  • Franklin Street Advisors fully exited Ralph Lauren in Q3 2015, selling an estimated $7.08M.
  • Franklin Street Advisors's ten largest holdings make up 27% of its $504M portfolio in Q3 2015.
  • Franklin Street Advisors opened 25 new positions and closed 24 in Q3 2015.
  • Franklin Street Advisors's portfolio value fell 9.7% quarter-over-quarter to $504M.

Based on Franklin Street Advisors's 13F filing for Q3 2015, filed 9 Oct 2015.